Innovate UK

Founded in 2007, Innovate UK is a non-profit organization based in Swindon, UK. It supports businesses across various economic sectors by offering funding services to promote science and technology innovations.

Mike Biddle

Programme Director of Industrial Strategy Challenge Fund

Will Drury

Executive Director, Digital and Technologies

Paul Gadd

Deputy Director

Dr. Tom Jenkins

Deputy Director

Scott James O'Brien

Director, Innovation Finance

Nigel Walker

Deputy Director, Lending and Investor Partnerships

Past deals in Dietary Supplements

Biovit

Grant in 2024
Biovit is a company that specializes in the development of fortified foods. It uses 100% organic plant extracts, naturally rich in vitamins and minerals, to enhance the nutritional value of its products. The company aims to address health and environmental issues such as obesity and malnutrition, while also reducing food waste. Biovit has clinically developed and tested organic micronutrient blends for use in various food and beverage products, as well as supplements, providing consumers with organically sourced, nutrient-dense options.

BoobyBiome

Grant in 2024
BoobyBiome operates a microbiome research platform and develops probiotic supplements for infants with compromised microbiomes, including premature babies, to promote gut health and immune development by closely mirroring the beneficial bacteria found in breast milk.

The Good Pulse Company

Grant in 2023
The Good Pulse Company develops functional proteins and ingredients derived from pulses for use in plant-based foods and supplements, including plant-based cheeses and meats. It concentrates on maximizing the functionality and nutritional value of components extracted from pulse seeds such as peas and soy, and pursues the production of functional meat proteins through precision fermentation to offer sustainable, ethical food options without compromising taste or experience.

Calla Lily Clinical Care

Grant in 2023
Calla Lily Clinical Care is a women's health company focused on developing innovative drug delivery systems. Their proprietary platform, Callavid®, enables intravaginal drug delivery for various indications, including fertility and pregnancy support, prevention of recurrent bacterial vaginosis, hormone replacement therapy for menopause, and biomarker-based diagnostic tests.

BoobyBiome

Pre Seed Round in 2022
BoobyBiome operates a microbiome research platform and develops probiotic supplements for infants with compromised microbiomes, including premature babies, to promote gut health and immune development by closely mirroring the beneficial bacteria found in breast milk.

BoobyBiome

Grant in 2022
BoobyBiome operates a microbiome research platform and develops probiotic supplements for infants with compromised microbiomes, including premature babies, to promote gut health and immune development by closely mirroring the beneficial bacteria found in breast milk.

BoobyBiome

Grant in 2022
BoobyBiome operates a microbiome research platform and develops probiotic supplements for infants with compromised microbiomes, including premature babies, to promote gut health and immune development by closely mirroring the beneficial bacteria found in breast milk.

Calla Lily Clinical Care

Grant in 2021
Calla Lily Clinical Care is a women's health company focused on developing innovative drug delivery systems. Their proprietary platform, Callavid®, enables intravaginal drug delivery for various indications, including fertility and pregnancy support, prevention of recurrent bacterial vaginosis, hormone replacement therapy for menopause, and biomarker-based diagnostic tests.

Camallergy

Grant in 2021
Founded in 2015 and based in Cambridge, UK, Camallergy is a biopharmaceutical company focused on developing innovative treatments for food allergies. Its lead product is an oral immunotherapy designed to provide significant protection against peanut allergy within just three months.

Nandi Proteins

Grant in 2016
Nandi Proteins Limited is a UK-based company, established in 2000 and spun out of Heriot Watt University in 2001. Formerly known as Nandi Biotechnology Limited, the company specializes in developing innovative technologies to enhance the functional properties of proteins used in food manufacturing and nutrition. Nandi Proteins focuses on improving common proteins such as whey, egg, and soy through patented processes that utilize controlled heat, time, and temperature. The company's goal is to lead the market in denatured protein technology, offering value-added protein products and pursuing strategic licensing agreements with industry partners. By leveraging its expertise, Nandi Proteins aims to deliver significant growth and provide manufacturers with the ability to enhance the physical characteristics and health benefits of food and beverage products while also enabling the cost-effective extraction of valuable components.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.